Nunn Jason Raleigh
Insider CIK 1444319 · TSPT Director · HPTX Director · TRVN Director · TRIV Director · RGLS Director · DERM Director · ADXN Director · ZBIO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 50,000 | — | $0 | 0 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award | 2026-09-02 | 2026-09-04 | 219,561 | — | $0 | 219,561 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer | 2026-09-02 | 2026-09-04 | 219,561 | — | $0 | 0 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award deriv | 2026-09-02 | 2026-09-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer deriv | 2026-09-02 | 2026-09-04 | 50,000 | — | $0 | 0 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | A Award | 2026-09-02 | 2026-09-04 | 219,561 | — | $0 | 219,561 | SEC↗ |
| ADXN Addex Therapeutics Ltd. | D To issuer | 2026-09-02 | 2026-09-04 | 219,561 | — | $0 | 0 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2026-06-15 | 2026-06-17 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2025-10-09 | 2025-10-14 | 63,158 | $19.00 | $1.20M | 1,173,395 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 15,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 60,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 4,650 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 2,325 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 4,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 9,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 30,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer | 2025-06-25 | 2025-06-27 | 62,500 | — | $0 | 0 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 18,500 | — | $0 | 18,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2025-04-30 | 2025-04-30 | 62,500 | — | $0 | 62,500 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-16 | 13,071,439 | — | $0 | 0 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-16 | 5,809,528 | — | $0 | 0 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2024-09-16 | 2024-09-16 | 441,176 | $17.00 | $7.50M | 1,110,237 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | P Buy | 2024-09-16 | 2024-09-16 | 441,176 | $17.00 | $7.50M | 1,946,564 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | C Conversion | 2024-09-16 | 2024-09-16 | 669,061 | — | $0 | 669,061 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | C Conversion | 2024-09-16 | 2024-09-16 | 1,505,388 | — | $0 | 1,505,388 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2024-09-12 | 2024-09-16 | 37,000 | — | $0 | 37,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2024-06-13 | 2024-06-14 | 13,700 | — | $0 | 13,700 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-05-20 | 2024-05-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-05-16 | 2024-05-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-08-10 | 2023-08-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2023-06-15 | 2023-06-20 | 13,700 | — | $0 | 13,700 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-06-13 | 2023-06-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 90,000 | — | $0 | 90,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2022-06-09 | 2022-06-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2021-06-14 | 2021-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2021-05-28 | 2021-06-02 | 68,577 | — | $0 | 68,577 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2020-06-17 | 2020-06-19 | 23,250 | — | $0 | 23,250 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2020-05-13 | 2020-05-15 | 64,103 | — | $0 | 64,103 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 3,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 6,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 6,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 10,344 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 10,334 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 6,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer | 2020-02-20 | 2020-02-24 | 6,000 | $18.75 | $112.5K | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-10-10 | 2019-10-15 | 46,500 | — | $0 | 46,500 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2019-06-12 | 2019-06-14 | 3,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2019-06-12 | 2019-06-14 | 3,000 | — | $0 | 6,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-06-04 | 2019-06-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-06-04 | 2019-06-06 | 3,000 | — | $0 | 3,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2019-05-16 | 2019-05-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2018-06-13 | 2018-06-14 | 3,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2018-06-13 | 2018-06-14 | 3,000 | — | $0 | 3,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-06-12 | 2018-06-14 | 6,000 | — | $0 | 6,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-06-12 | 2018-06-14 | 3,000 | — | $0 | 3,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2018-05-16 | 2018-05-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2017-06-13 | 2017-06-15 | 3,000 | — | $0 | 3,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2017-06-13 | 2017-06-15 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2017-05-17 | 2017-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2016-06-21 | 2016-06-23 | 10,344 | — | $0 | 10,344 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2016-06-21 | 2016-06-30 | 10,344 | — | $0 | 10,344 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2016-05-18 | 2016-05-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TRVN TREVENA INC | J Other | 2015-12-09 | 2015-12-10 | 4,271 | — | $0 | 4,271 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2015-06-11 | 2015-06-15 | 10,344 | — | $0 | 10,344 | SEC↗ |
| TRIV TriVascular Technologies, | A Award deriv | 2015-05-22 | 2015-05-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2015-05-20 | 2015-05-21 | 8,870 | — | $0 | 8,870 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-11 | 11,855 | $46.00 | $545.3K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-11 | 4,869 | $46.00 | $224.0K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-11 | 9,800 | $46.00 | $450.8K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer deriv | 2015-05-07 | 2015-05-11 | 4,105 | $46.00 | $188.8K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | U Tender | 2015-05-07 | 2015-05-11 | 70 | $46.00 | $3.2K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | D To issuer | 2015-05-07 | 2015-05-11 | 2,617 | $46.00 | $120.4K | 0 | SEC↗ |
| TSPT Transcept Pharmaceuticals | D To issuer deriv | 2014-10-30 | 2014-10-30 | 158 | — | $0 | 0 | SEC↗ |
| TSPT Transcept Pharmaceuticals | D To issuer deriv | 2014-10-30 | 2014-10-30 | 583 | — | $0 | 0 | SEC↗ |
| TSPT Transcept Pharmaceuticals | D To issuer deriv | 2014-10-30 | 2014-10-30 | 583 | — | $0 | 0 | SEC↗ |
| TSPT Transcept Pharmaceuticals | D To issuer deriv | 2014-10-30 | 2014-10-30 | 1,125 | — | $0 | 0 | SEC↗ |
| TSPT Transcept Pharmaceuticals | D To issuer deriv | 2014-10-30 | 2014-10-30 | 333 | — | $0 | 0 | SEC↗ |
| TSPT Transcept Pharmaceuticals | D To issuer deriv | 2014-10-30 | 2014-10-30 | 833 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other | 2014-06-05 | 2014-06-06 | 70 | — | $0 | 70 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2014-05-27 | 2014-05-29 | 4,869 | — | $0 | 4,869 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award | 2014-05-27 | 2014-05-29 | 2,617 | — | $0 | 2,617 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2014-05-14 | 2014-05-15 | 8,870 | — | $0 | 8,870 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award deriv | 2013-04-15 | 2013-05-01 | 9,800 | — | $0 | 9,800 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2013-01-07 | 2013-01-09 | 13,500 | — | $0 | 13,500 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2012-01-24 | 2012-01-26 | 7,000 | — | $0 | 7,000 | SEC↗ |